Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytonix is a materials science company specializing in the development and manufacture of high-performance fluoropolymer coatings for the life sciences, electronics, and aerospace sectors. Based in Beltsville, Maryland, the company is a key provider of hydrophobic and oleophobic surface treatments, most notably the FluoroPel and CytoPel product lines. In the biotechnology industry, these coatings are essential for creating low-retention laboratory consumables such as pipette tips, microfluidic devices, and PCR plates. The technology ensures the precise handling of small fluid volumes by preventing the adhesion of proteins, nucleic acids, and other biomolecules to plastic and glass surfaces. This capability is critical for maintaining sample integrity and preventing cross-contamination in high-sensitivity applications like Next-Generation Sequencing (NGS) and molecular diagnostics. In addition to its coating products, Cytonix manufactures specialized equipment for surface modification and provides custom coating services for medical device manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cytonix.